Advanced search
Publication Cover
Cancer Investigation Volume 36, 2018 - Issue 9-10
Submit an article Journal homepage
281
Views
4
CrossRef citations to date
0
Altmetric
Articles

Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors

Maria Dinche JohansenDepartment of Radiation Biology, Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-1069-8428View further author information
ORCID Icon,
Thomas UrupDepartment of Radiation Biology, Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Camilla Bjørnbak HolstDepartment of Radiation Biology, Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Ib Jarle ChristensenDepartment of Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark; View further author information
,
Kirsten GrunnetDepartment of Radiation Biology, Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Ulrik LassenDepartment of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; View further author information
,
Søren FriisDanish Cancer Society, Danish Cancer Society Research Center, Copenhagen, DenmarkView further author information
&
Hans Skovgaard PoulsenDepartment of Radiation Biology, Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen, Denmark; View further author information
 show all
Pages 512-519 | Received 30 Jan 2018, Accepted 01 Nov 2018, Published online: 07 Jan 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.